International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Allyn C. Howlett1,2,3,4,5,6,7,8
110Department of Biomedical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom (R.G.P.)
21Sanofi-Synthelabo Recherche, Montpellier, Cedex, France (F.B., P.C.)
32Laboratory of Genetics (T.I.B.) and
3Section on Functional Neuroanatomy (M.H.), National Institute of Mental Health, Bethesda, Maryland
46Eli Lilly & Co. Ltd., Lilly Research Centre, Windlesham, Surrey, United Kingdom (C.C.F.)
57Neuroscience of Drug Abuse Program, Julius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University, Durham, North Carolina (A.H.)
68Department of Anesthesiology, University of Washington, Seattle, Washington (K.M.)
79Department of Natural Products, Hebrew University, Medical Faculty, El Kerem Campus, Jerusalem, Israel (R.M.)
8Departments of
4Microbiology and Immunology (G.C.) and
5Pharmacology and Toxicology (W.A.D., B.R.M.), Virginia Commonwealth University, Richmond, Virginia
Tóm tắt
Từ khóa
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Pharmacological Reviews
Tập 54 Số 2
161-202
Thông tin tác giả